115 related articles for article (PubMed ID: 3546350)
21. What are the physical characteristics associated with a normal metabolic profile despite a high level of obesity in postmenopausal women?
Brochu M; Tchernof A; Dionne IJ; Sites CK; Eltabbakh GH; Sims EA; Poehlman ET
J Clin Endocrinol Metab; 2001 Mar; 86(3):1020-5. PubMed ID: 11238480
[TBL] [Abstract][Full Text] [Related]
22. Insulin sensitivity and body composition in cirrhosis: changes after TIPS.
Holland-Fischer P; Nielsen MF; Vilstrup H; Tønner-Nielsen D; Mengel A; Schmitz O; Grønbaek H
Am J Physiol Gastrointest Liver Physiol; 2010 Aug; 299(2):G486-93. PubMed ID: 20489042
[TBL] [Abstract][Full Text] [Related]
23. The influence of fatty liver on insulin clearance and insulin resistance in non-diabetic Japanese subjects.
Goto T; Onuma T; Takebe K; Kral JG
Int J Obes Relat Metab Disord; 1995 Dec; 19(12):841-5. PubMed ID: 8963349
[TBL] [Abstract][Full Text] [Related]
24. The involvement of the opioid system in human obesity: a study in normal weight relatives of obese people.
Cozzolino D; Sessa G; Salvatore T; Sasso FC; Giugliano D; Lefebvre PJ; Torella R
J Clin Endocrinol Metab; 1996 Feb; 81(2):713-8. PubMed ID: 8636293
[TBL] [Abstract][Full Text] [Related]
25. Decreased insulin removal contributes to hyperinsulinemia in obesity.
Faber OK; Christensen K; Kehlet H; Madsbad S; Binder C
J Clin Endocrinol Metab; 1981 Sep; 53(3):618-21. PubMed ID: 7021583
[TBL] [Abstract][Full Text] [Related]
26. Contribution of obesity to insulin resistance in noninsulin-dependent diabetes mellitus.
Perriello G; Misericordia P; Volpi E; Pampanelli S; Santeusanio F; Brunetti P; Bolli GB
J Clin Endocrinol Metab; 1995 Aug; 80(8):2464-9. PubMed ID: 7629243
[TBL] [Abstract][Full Text] [Related]
27. Impaired incretin effect and fasting hyperglucagonaemia characterizing type 2 diabetic subjects are early signs of dysmetabolism in obesity.
Knop FK; Aaboe K; Vilsbøll T; Vølund A; Holst JJ; Krarup T; Madsbad S
Diabetes Obes Metab; 2012 Jun; 14(6):500-10. PubMed ID: 22171657
[TBL] [Abstract][Full Text] [Related]
28. Effects of biliopancreatic diversion on diurnal leptin, insulin and free fatty acid levels.
Raffaelli M; Iaconelli A; Nanni G; Guidone C; Callari C; Fernandez Real JM; Bellantone R; Mingrone G
Br J Surg; 2015 May; 102(6):682-90. PubMed ID: 25808987
[TBL] [Abstract][Full Text] [Related]
29. Very low calorie diet-induced weight loss reverses exaggerated insulin secretion in response to glucose, arginine and glucagon in obesity.
Numata K; Tanaka K; Saito M; Shishido T; Inoue S
Int J Obes Relat Metab Disord; 1993 Feb; 17(2):103-8. PubMed ID: 8384164
[TBL] [Abstract][Full Text] [Related]
30. Effects of oral L-carnitine supplementation on insulin sensitivity indices in response to glucose feeding in lean and overweight/obese males.
Galloway SD; Craig TP; Cleland SJ
Amino Acids; 2011 Jul; 41(2):507-15. PubMed ID: 20963457
[TBL] [Abstract][Full Text] [Related]
31. An in vivo and in vitro study of the mechanism of prednisone-induced insulin resistance in healthy subjects.
Pagano G; Cavallo-Perin P; Cassader M; Bruno A; Ozzello A; Masciola P; Dall'omo AM; Imbimbo B
J Clin Invest; 1983 Nov; 72(5):1814-20. PubMed ID: 6355186
[TBL] [Abstract][Full Text] [Related]
32. The molar ratio of C-peptide to insulin after two consecutive stimulations with glucagon in obesity.
Vannini P; Ciavarella A; Flammini M; Forlani G; Capelli M; Cocchi V
Int J Obes; 1982; 6(4):327-34. PubMed ID: 6752059
[TBL] [Abstract][Full Text] [Related]
33. Glucose handling in morbid obesity and the effects of surgically induced weight loss.
Dooner J; Burget D; Cleator IG
JPEN J Parenter Enteral Nutr; 1984; 8(6):660-4. PubMed ID: 6394779
[TBL] [Abstract][Full Text] [Related]
34. Beta and alpha cell function in metabolically healthy but obese subjects: relationship with entero-insular axis.
Calanna S; Piro S; Di Pino A; Maria Zagami R; Urbano F; Purrello F; Maria Rabuazzo A
Obesity (Silver Spring); 2013 Feb; 21(2):320-5. PubMed ID: 23404781
[TBL] [Abstract][Full Text] [Related]
35. Quantitative study of insulin secretion and clearance in normal and obese subjects.
Polonsky KS; Given BD; Hirsch L; Shapiro ET; Tillil H; Beebe C; Galloway JA; Frank BH; Karrison T; Van Cauter E
J Clin Invest; 1988 Feb; 81(2):435-41. PubMed ID: 3276729
[TBL] [Abstract][Full Text] [Related]
36. Insulin secretion, clearance and action before and after gastroplasty in severely obese subjects.
Letiexhe MR; Scheen AJ; Gérard PL; Desaive C; Lefèbvre PJ
Int J Obes Relat Metab Disord; 1994 May; 18(5):295-300. PubMed ID: 8061722
[TBL] [Abstract][Full Text] [Related]
37. Restored insulin inhibition on insulin secretion in nondiabetic severely obese patients after weight loss induced by bariatric surgery.
Pereira JA; Claro BM; Pareja JC; Chaim EA; Astiarraga BD; Saad MJ; Muscelli E
Int J Obes Relat Metab Disord; 2003 Apr; 27(4):463-8. PubMed ID: 12698955
[TBL] [Abstract][Full Text] [Related]
38. Peripheral hyperinsulinemia of simple obesity: pancreatic hypersecretion or impaired insulin metabolism?
Bonora E; Zavaroni I; Bruschi F; Alpi O; Pezzarossa A; Guerra L; Dall'Aglio E; Coscelli C; Butturini U
J Clin Endocrinol Metab; 1984 Dec; 59(6):1121-7. PubMed ID: 6386838
[TBL] [Abstract][Full Text] [Related]
39. Altered C-peptide/insulin molar ratios and glucose turnover rates after stimulation in nondiabetic offsprings of type II diabetic patients.
Osei K; Holland GC
Metabolism; 1987 Feb; 36(2):122-7. PubMed ID: 3543613
[TBL] [Abstract][Full Text] [Related]
40. Effects of morbid obesity on insulin clearance and insulin sensitivity in several aspects of metabolism as assessed by low-dose insulin infusion.
Robertson DA; Singh BM; Hale PJ; Nattrass M
Metabolism; 1992 Jun; 41(6):604-12. PubMed ID: 1640847
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
